NCT04129138View on ClinicalTrials.gov

Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose

Active, not recruitingOBSERVATIONAL

Enrollment

182

Participants

Timeline

Start Date

July 18, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

CaregiverPatient

Interventions

OTHER

Survey Administration

Complete survey

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER